MLICM
PRTA icon

Metropolitan Life Insurance Company (MetLife)’s Prothena Corp PRTA Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio PRTA Stock Details PRTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-2,317
Closed -$57.4K – 1605
2024
Q1 		$57.4K Sell
2,317
-72
-3% -$2.14K ﹤0.01% 1337
2023
Q4 		$86.8K Hold
2,389
– – ﹤0.01% 1163
2023
Q3 		$115K Buy
2,389
+125
+6% +$7.43K 0.01% 932
2023
Q2 		$155K Buy
+2,264
New +$146K 0.01% 797
2023
Q1 		– Sell
-2,329
Closed -$140K – 2432
2022
Q4 		$140K Hold
2,329
– – 0.01% 879
2022
Q3 		$141K Hold
2,329
– – 0.01% 826
2022
Q2 		$63.2K Hold
2,329
– – ﹤0.01% 1341
2022
Q1 		$85.2K Sell
2,329
-6,951
-75% -$251K ﹤0.01% 1297
2021
Q4 		$458K Hold
9,280
– – 0.01% 1502
2021
Q3 		$661K Buy
+9,280
New +$576K 0.01% 1262
2021
Q2 		– Sell
-9,566
Closed -$240K – 2841
2021
Q1 		$240K Sell
9,566
-375
-4% -$7.05K ﹤0.01% 1890
2020
Q4 		$119K Buy
9,941
+3,005
+43% +$35.5K ﹤0.01% 2264
2020
Q3 		$69.3K Sell
6,936
-5,819
-46% -$70K ﹤0.01% 2408
2020
Q2 		$133K Hold
12,755
– – ﹤0.01% 2080
2020
Q1 		$136K Buy
12,755
+851
+7% +$10.3K ﹤0.01% 1836
2019
Q4 		$188K Sell
11,904
-1,115
-9% -$12K ﹤0.01% 1968
2019
Q3 		$102K Hold
13,019
– – ﹤0.01% 2292
2019
Q2 		$138K Hold
13,019
– – ﹤0.01% 2143
2019
Q1 		$158K Hold
13,019
– – ﹤0.01% 2058
2018
Q4 		$134K Hold
13,019
– – ﹤0.01% 2087
2018
Q3 		$170K Buy
+13,019
New +$188K ﹤0.01% 2115
2014
Q3 		– Sell
-17,383
Closed -$388K – 2711
2014
Q2 		$388K Buy
17,383
+6,670
+62% +$167K ﹤0.01% 2021
2014
Q1 		$410K Hold
10,713
– – ﹤0.01% 1951
2013
Q4 		$284K Hold
10,713
– – ﹤0.01% 2219
2013
Q3 		$217K Buy
+10,713
New +$190K ﹤0.01% 2363

Other funds holding PRTA

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s PRTA Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Prothena Corp (PRTA) in Q2 2024, closing a stake of 2,317 shares — an estimated $57.4K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in PRTA in Q3 2013 and held it in 25 quarters. The position peaked at $661K in Q3 2021. 160 funds tracked by Wall St. Rank hold PRTA as of Q2 2024.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Prothena Corp position as of Q2 2024 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 2,317 Prothena Corp shares in Q2 2024, an estimated $57.4K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Prothena Corp in Q3 2013 and held it in 25 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Prothena Corp position peaked at $661K in Q3 2021.
  • 160 funds tracked by Wall St. Rank held Prothena Corp as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.